Stay updated on Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial
Sign up to get notified when there's something new on the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page.

Latest updates to the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.6.3 was added and Revision: v3.6.1 was removed, indicating a version update. This change pertains to metadata about the page version rather than substantive content changes.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.1, indicating a minor platform update. The study details and user interactions remain unchanged.SummaryDifference0.0%

- Check20 days agoChange DetectedRecruitment status was updated to indicate the study is not seeking participants, and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment label was introduced and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check27 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, signaling a small backend/template update without altering the displayed study details.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, reflecting a minor version increment for the page documentation.SummaryDifference0.0%

- Check62 days agoChange DetectedThe Taiwan site address now specifies Taoyuan City instead of Taoyuan, clarifying the city designation for the address while keeping the postal code 33305 the same.SummaryDifference0.0%

Stay in the know with updates to Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page.